Oncology

A multiple cohort study sponsored by the National Cancer Institute and Veterans Affairs Health System was conducted to determine if black men suffer at a higher prostate cancer mortality rate than non-Hispanic white men. Numerous trials have resulted in conflicting findings pertaining to the association between prostate mortality rate and association with other-cause mortality rates...

Participation rates similar for Black and White patients, treatment and cancer control trials More than half of patients offered participation in cancer clinical trials are willing to participate, according to a study published online Oct. 6 in the Journal of the National Cancer Institute to coincide with the ASCO Quality Care Symposium, held virtually from...

By Dr. Mark Abdelmalek and Lucien bruggeman At the onset of the novel coronavirus, American healthcare providers sought to limit non-essential in-person visits, opting instead to put off routine examinations – including annual cancer screenings – as part of an effort to curb risky face-to-face interactions. This precautionary approach was endorsed by the American Cancer Society,...

Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment. Over the last decade, enzalutamide and similar drugs have led to significant tumor control and increased survival time for men who have metastatic prostate cancer that continues to grow despite treatments to reduce male hormone levels. About...

Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80 percent Prostate cancer clinical trial participants are overwhelmingly white, according to a study published online June 5 in Cancer Epidemiology, Biomarkers & Prevention. Emily M. Rencsok, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues analyzed 72 global...

By Robin Baumeister When celebrities share their lives on social media, we might expect to see their hobbies, meals, or vacations—definitely not their colonoscopies. But that is exactly what Black-ish star Anthony Anderson did, and for good reason: he wants to make sure that men of color don’t miss this routine exam.  So why are...

Article by. Gerardo Sison Genetic testing is at the forefront of precision medicine and state-of-the-art treatments for cancer. Precision medicine is a valuable part of oncology as it allows cancer patients to receive targeted treatment, avoid adverse events, and experience optimal outcomes. Through precision medicine, physicians can apply more comprehensive treatment methods that revolve around...

MD Newsline recently interviewed urologist and Cofounder of MedAux Dr. Behzad Jazayeri about PSA testing and prostate cancer health disparities in Black men. MD Newsline: Dr. Jazayeri, several studies have found that prostate cancer is more common amongst black men. What makes them much more susceptible? Dr. Jazayeri: This is a question that we have...

Gleason grade, prostate-specific antigen velocity, and imaging markers predict cancer spread FRIDAY, Nov. 20, 2020  — Active surveillance for low-risk prostate cancer is associated with a low risk for cancer spread, according to a study published in the Dec. 1 issue of The Journal of Urology. Peter E. Lonergan, M.D., from the University of California...